Physician

Abhilasha Pandey, M.D

According to 2025 Medicare claims, Abhilasha Pandey, M.D (NPI: 1598053415) practices endocrinology in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Oakland, MI. This provider's primary affiliated billing organization is ALLY ENDOCRINOLOGY PLLC (NPI: 1255900395; TIN: 871311247) and primary practice location at 48084-7069. Pandey is affiliated with the St. John Providence ACO, LLC (ACO ID: A5417), participating under the MSSP model.

Pandey's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 243 traditional Medicare patients, billed 715 HCPCS/CPT codes, and received $54,692 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,030 prescription claims across 201 beneficiaries totaling $471,449 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 74 claims. Open Payments data shows 55 records totaling $1,617. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $11,157 to $54,692. Similarly, Part D prescription costs have moved sharply higher in recent years, from $314 to $471,449. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $288 and ending at $33,846.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	135	209	$11,157
2017	106	167	$8,891
2018	107	255	$15,456
2019	72	165	$8,196
2020	N/R	N/R	N/R
2021	41	84	$5,771
2022	252	563	$38,825
2023	229	474	$38,654
2024	243	715	$54,692

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	11	19	$314
2016	196	1,138	$63,696
2017	201	1,531	$83,255
2018	239	1,319	$75,609
2019	204	1,672	$160,394
2020	103	315	$92,293
2021	41	129	$44,326
2022	60	211	$116,999
2023	111	618	$353,798
2024	201	1,030	$471,449

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	19	$321
2018	N/R	16	$221
2019	N/R	24	$252
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	32	$5,838
2024	18	74	$25,442

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	64	64	$121
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	75	77	$94
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	120	308	$94
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	44	67	$67
99231	Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes	38	53	$38

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	62	1,964	$70,856
Jardiance	Empagliflozin	49	3,540	$65,610
Ozempic	Semaglutide	45	1,672	$50,809
Rybelsus	Semaglutide	26	1,620	$46,779
Januvia	Sitagliptin Phosphate	31	2,370	$40,920

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	18	49	$21,547
E0784	External ambulatory infusion pump, insulin	Y	N/R	11	$3,514
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	14	$382

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	55	$1,617	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abhilasha Pandey, M.D?

Tedicare shows public-source Medicare data for Abhilasha Pandey, M.D (NPI 1598053415), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abhilasha Pandey, M.D have ACO affiliation data?

Abhilasha Pandey, M.D is shown with ACO affiliation data for St. John Providence ACO, LLC (MSSP, ACO ID A5417).

What billing organization is linked to Abhilasha Pandey, M.D?

Abhilasha Pandey, M.D is linked to ALLY ENDOCRINOLOGY PLLC (billing NPI 1255900395) in the available physician profile data.

Does Abhilasha Pandey, M.D have Open Payments data?

Abhilasha Pandey, M.D has 55 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.